tradingkey.logo
tradingkey.logo
Search

Biofrontera Inc

BFRI
Add to Watchlist
1.010USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
11.76MMarket Cap
LossP/E TTM

More Details of Biofrontera Inc Company

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Biofrontera Inc Info

Ticker SymbolBFRI
Company nameBiofrontera Inc
IPO dateOct 14, 2021
CEOLuebbert (Hermann)
Number of employees92
Security typeOrdinary Share
Fiscal year-endOct 14
Address120 Presidential Way,
CityWOBURN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01801
Phone17812451325
Websitehttps://www.biofrontera-us.com/
Ticker SymbolBFRI
IPO dateOct 14, 2021
CEOLuebbert (Hermann)

Company Executives of Biofrontera Inc

Name
Name/Position
Position
Shareholding
Change
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Mr. George Jones
Mr. George Jones
Chief Commercial Officer
Chief Commercial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--

FAQs

Who are the top five shareholders of Biofrontera Inc?

The top five shareholders of Biofrontera Inc are: Prof. Dr. Hermann Luebbert, Ph.D.

How many institutions hold shares of Biofrontera Inc (BFRI)?

As of 2026Q1, 37 institutions hold shares of Biofrontera Inc, with a combined market value of approximately 2.75M, accounting for 22.90% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -276665.00.